Cargando…

Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning

Supplemental digital content is available in the text.

Detalles Bibliográficos
Autores principales:	Ivanova, Svetlana A., Dröge, Melloney J., Volders, Haukeline H., van Vliet, Bernard J., Bokhan, Nikolay A., Bosker, Fokko J., Loonen, Anton J.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Letters to the Editors — Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039400/ https://www.ncbi.nlm.nih.gov/pubmed/29912796 http://dx.doi.org/10.1097/JCP.0000000000000914

Ejemplares similares

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020)

Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients
por: Losenkov, Innokentiy S., et al.
Publicado: (2020)

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
por: Boiko, Anastasiia S., et al.
Publicado: (2019)

Association of PIP4K2A Polymorphisms with Alcohol Use Disorder
por: Fedorenko, Olga Yu., et al.
Publicado: (2021)

The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders
por: Levchenko, Anastasia, et al.
Publicado: (2018)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
por: Boiko, Anastasiia S, et al.
Publicado: (2020)

Genetic polymorphisms of PIP5K2A and course of schizophrenia
por: Poltavskaya, Evgeniya G., et al.
Publicado: (2020)

Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms
por: Poltavskaya, Evgeniya G., et al.
Publicado: (2021)

The evolutionary old forebrain as site of action to develop new psychotropic drugs
por: Loonen, Anton JM, et al.
Publicado: (2018)

Neurobiological mechanisms associated with antipsychotic drug-induced dystonia
por: Loonen, Anton JM, et al.
Publicado: (2020)

5- Hydroxytryptamine
por: Giarman, Nicholas J.
Publicado: (1958)

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
por: Mednova, Irina A., et al.
Publicado: (2020)

Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
por: Kornetova, Elena G., et al.
Publicado: (2019)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

A New Paradigm to Indicate Antidepressant Treatments
por: Loonen, Anton J. M., et al.
Publicado: (2021)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

STORAGE OF 5-HYDROXYTRYPTAMINE IN MEGAKARYOCYTES
por: Tranzer, J. P., et al.
Publicado: (1972)

Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia
por: Fedorenko, Olga Yu, et al.
Publicado: (2015)

Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding
por: Ivanova, Svetlana A., et al.
Publicado: (2016)

Circuits regulating pleasure and happiness: the evolution of reward-seeking and misery-fleeing behavioral mechanisms in vertebrates
por: Loonen, Anton J. M., et al.
Publicado: (2015)

Circuits Regulating Pleasure and Happiness—Mechanisms of Depression
por: Loonen, Anton J. M., et al.
Publicado: (2016)

Circuits Regulating Pleasure and Happiness: The Evolution of the Amygdalar-Hippocampal-Habenular Connectivity in Vertebrates
por: Loonen, Anton J. M., et al.
Publicado: (2016)

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design
por: Geers, Lisanne M., et al.
Publicado: (2021)

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia
por: Paderina, Diana Z., et al.
Publicado: (2021)

Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression
por: Ochi, Taichi, et al.
Publicado: (2019)

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action
por: Ochi, Taichi, et al.
Publicado: (2021)

Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression
por: Roschina, Olga V., et al.
Publicado: (2021)

Exploring the paradigm of depressive disorders through an evolutionary and biopsychosocial lens
por: Ochi, T., et al.
Publicado: (2023)

Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia
por: Pozhidaev, Ivan V, et al.
Publicado: (2020)

Circuits Regulating Pleasure and Happiness in Bipolar Disorder
por: Loonen, Anton J. M., et al.
Publicado: (2017)

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals
por: Kornetova, Elena G., et al.
Publicado: (2021)

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome
por: Boiko, Anastasiia S., et al.
Publicado: (2022)

Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
por: Boiko, Anastasiia S, et al.
Publicado: (2021)

Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome
por: Kornetova, Elena G., et al.
Publicado: (2020)

N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
por: Yang, Chenghao, et al.
Publicado: (2018)

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
por: Fedorenko, Olga Yu., et al.
Publicado: (2022)

Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations
por: Ivanova, Svetlana A, et al.
Publicado: (2016)

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia
por: Paderina, Diana Z., et al.
Publicado: (2022)

Serum Growth Factors in Schizophrenia Patients
por: Boiko, Anastasiia S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_badvbti3838dk06d7p1asv5lr5